Bora Pharmaceuticals Completes Acquisition of MacroGenics' Rockville Manufacturing Operations
Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group") (TWSE:6472)(OTCQX:BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ:MGNX), including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon...
Read more







